Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen
NCT00018343 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2009-01-21
Summary
This study is designed to evaluate the potential beneficial effects of estrogen on cognitive function of women with Alzheimer's Disease.
Conditions
Interventions
- DRUG
Sponsors & Collaborators
-
US Department of Veterans Affairs
lead FED
Principal Investigators
-
Suzanne Craft, Ph.D
-
Laura Baker, Ph.D
-
Murray Raskind, M.D.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 50 Years
- Max Age
- 90 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1998-04-30
- Completion
- 2001-03-31
Countries
- United States
Study Locations
More Related Trials
-
Estrogen Modulation of Mood and Cognition Following Monoaminergic Depletion in Post-Menopausal Women
NCT00005768 ·Status: UNKNOWN ·Phase: PHASE2
-
Effects of Ovarian Hormone Suppression on Vascular and Cognitive Function
NCT03112226 ·Status: COMPLETED ·Phase: NA
-
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
NCT02122198 ·Status: COMPLETED ·Phase: NA
-
Estrogen Hormone Protocol
NCT00000177 ·Status: COMPLETED ·Phase: PHASE3
-
Estrogen, HDL, and Coronary Heart Disease in Women
NCT00083824 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Early Menopause Hormone Treatment and Cognition
NCT01046643 ·Status: COMPLETED ·Phase: NA
-
The Effects of Estrogen Withdrawal on Mood Symptoms in Women
NCT00060736 ·Status: COMPLETED
-
Perimenopausal Estrogen Replacement Therapy Study
NCT01308814 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Clinical Study to Evaluate the Effects of Estrogen in Healthy Postmenopausal Women
NCT00820664 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of a Tissue Selective Estrogen Complex (TSEC) on Depression and the Neural Reward System in the Perimenopause"
NCT03740009 ·Status: COMPLETED ·Phase: PHASE4
-
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease
NCT03821857 ·Status: RECRUITING ·Phase: PHASE4
-
Estrogen Replacement and Atherosclerosis (ERA) in Older Women
NCT00000549 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Estradiol on Endothelial Function in Peri-Menopausal Women
NCT04255160 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Hormone Replacement Trial Against ALzheimers' Disease
NCT04312399 ·Status: RECRUITING ·Phase: NA
-
Menopause Effects on Vascular Function
NCT03236545 ·Status: COMPLETED ·Phase: NA
-
Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women
NCT01633814 ·Status: TERMINATED ·Phase: NA
-
Dose Effects of Hormone Therapy (Two Doses of Estradiol Associated to Progesterone) on Inflammatory Markers
NCT00236301 ·Status: TERMINATED ·Phase: PHASE3
-
Estrogen, Cytokines and Heart Failure in Women
NCT00041431 ·Status: COMPLETED ·Phase: NA
-
Effects of Hormone Replacement Therapy on Inflammation and Stiffening of Artery Walls
NCT00005108 ·Status: COMPLETED ·Phase: PHASE2
-
Phytoestrogens and Memory Decline in Menopause
NCT00051402 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Estradiol Topical Products
NCT05645393 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Estrogen Receptor Beta and Mood
NCT03689543 ·Status: COMPLETED ·Phase: PHASE2
-
Research Investigation of Soy and Estrogen
NCT00997893 ·Status: COMPLETED ·Phase: PHASE2
-
Women's Estrogen for Stroke Trial (WEST)
NCT00026039 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women
NCT02224313 ·Status: COMPLETED ·Phase: PHASE3